Cosmax Filed Patent for AI Alopecia Risk Model

The tool uses existing health data to predict hair loss risk, potentially helping you manage scalp health.

Updated on Sept. 30, 2026 in Beauty

Bold vector editorial illustration showing stylized, intertwined hair structures and light filaments, representing AI-driven dermatological health analysis. — Cosmax has patented an artificial intelligence model that analyzes health records to predict individual risk of alopecia areata. AI Illustration. Upload story photo >

Live Poll

Do you trust AI-driven personal health diagnostics to protect your private data?

Cosmax has filed a patent for an artificial intelligence model designed to predict the risk of alopecia areata. The technology relies on existing health records to analyze physiological markers without needing new biological samples.

Why it matters

This development represents a shift toward using large-scale health screening data to personalize dermatological care. By identifying individual risk factors earlier, the system could eventually help patients and doctors tailor hair loss prevention strategies.

The AI model was trained using 22 million health screening records from South Korea and Japan. It analyzes 33 distinct physiological and medical variables to generate its risk predictions, though the model remains in the patent-filing stage.

The players

Cosmax

A South Korean-based global research and manufacturing firm specializing in beauty and dermatological product development.

Seoul National University

A research institution that partnered with industry experts to develop hair-strengthening technology.

Fujishin

A Japanese distributor that partnered with developers to expand the reach of professional beauty solutions.

The details

The AI system functions by aggregating questionnaire responses and physiological metrics to assess scalp health patterns. It does not require additional biological testing, instead leveraging existing big data to identify correlations that contribute to hair loss. Separately, the company is using related research to restore cystine bonds in hair, which has demonstrated a 120 percent improvement in tensile strength in laboratory testing.

Cosmax filed 37 hair care patent applications over the past three years.
Hair care sales increased by 65 percent year-on-year in the first half of 2026.
Cosmax established the venture Trynex in July 2026.
The patent application for the AI model was announced on September 30, 2026.

Health Landscape

The AI model integrates with the Byniq personalized beauty platform to offer tailored scalp analysis. This patent application extends the capabilities of the existing Byniq platform by adding predictive diagnostic features to its current beauty-focused offerings.

While this tool is currently in the development and patent stage, it suggests a future where hair loss risk is monitored through routine health screenings. If you are concerned about hair thinning, consult your physician to discuss evidence-based screenings and established treatments.

The takeaway

Predictive AI models are increasingly being applied to dermatological conditions like alopecia to identify risks before symptoms appear. Always discuss new hair loss concerns with your primary care doctor or a board-certified dermatologist to establish an evidence-based care plan.